Bellevue Life Sciences Stock (NASDAQ: BLACW)

Latest news for Bellevue Life Sciences (NASDAQ:BLACW) Stock

Bellevue Life Sciences Acquisition Corp is a blank check company.

Bellevue Life Sciences Acquisition Corp. - Warrant

Bellevue Life Sciences Acquisition Corp

Telsey Advisory Group analyst Joseph Feldman maintains Tractor Supply (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSCO#NASDAQ">TSCO</a>) with a Outperform and maintains $335 price target.

News

Price Target

Analyst Ratings

TSCO

Telsey Advisory Group Maintains Outperform on Tractor Supply, Maintains $335 Price Target

BMO Capital analyst Etzer Darout initiates coverage on Jasper Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JSPR#NASDAQ">JSPR</a>) with a Outperform rating and announces Price Target of $63.

Initiation

Jasper Therapeutics, Inc. - Class A Common Stock

JSPR

BMO Capital Initiates Coverage On Jasper Therapeutics with Outperform Rating, Announces Price Target of $63

Baird analyst Eric Coldwell downgrades Fortrea Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) from Outperform to Neutral and lowers the price target from $28 to $25.

Downgrades

FTRE

Baird Downgrades Fortrea Holdings to Neutral, Lowers Price Target to $25

Telsey Advisory Group analyst Dana Telsey maintains Signet Jewelers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIG#NYSE">SIG</a>) with a Market Perform and maintains $87 price target.

Telsey Advisory Group Maintains Market Perform on Signet Jewelers, Maintains $87 Price Target

Needham analyst Mike Cikos maintains GitLab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) with a Buy and raises the price target from $70 to $85.

GTLB

Needham Maintains Buy on GitLab, Raises Price Target to $85

JFBR

Jeffs' Brands Says It Has Received A Written Notice From Nasdaq Stock Market, Indicating That The Company Has Regained Compliance With Minimum Bid Price Requirement For Continued Listing

Telsey Advisory Group analyst Dana Telsey maintains Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) with a Outperform and raises the price target from $360 to $430.

LULU

Telsey Advisory Group Maintains Outperform on Lululemon Athletica, Raises Price Target to $430

NVDA

Wipro Announced Pact With SIAM.AI, A Member Of NVIDIA Cloud Partner Program In Thailand To Build AI Assistant For Tourism Authority

Needham analyst Ryan MacDonald maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Buy and raises the price target from $260 to $270.

VEEV

Needham Maintains Buy on Veeva Systems, Raises Price Target to $270

Needham analyst Scott Berg reiterates UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) from Hold to Hold.

Reiteration

PATH

Needham Reiterates Hold on UiPathto Hold

Telsey Advisory Group analyst Dana Telsey maintains Victoria's Secret (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) with a Market Perform and maintains $40 price target.

VSCO

Telsey Advisory Group Maintains Market Perform on Victoria's Secret, Maintains $40 Price Target

Needham analyst Mayank Tandon reiterates Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) from Hold to Hold.

GWRE

Needham Reiterates Hold on Guidewire Softwareto Hold

BW LPG has today issued 2,141,000 new BW LPG shares to Avance Gas as part-consideration for the above vessel. Following the issuance of the new shares, the total number of issued shares of BW LPG is 149,641,000, representing a total share capital in the amount of USD 453,559,798. The new shares have been legally and validly issued and are fully paid.

BWLP

BW LPG Says It Has Taken Delivery Of Vessel BW Rigel On 6 December 2024; Six Of The 12 VLGCs Are Now Delivered

HC Wainwright &amp; Co. analyst Andres Maldonado reiterates CG Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGON#NASDAQ">CGON</a>) with a Buy and maintains $75 price target.

CGON

HC Wainwright & Co. Reiterates Buy on CG Oncology, Maintains $75 Price Target

Telsey Advisory Group analyst Dana Telsey maintains J.Jill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JILL#NYSE">JILL</a>) with a Market Perform and maintains $31 price target.

JILL

Telsey Advisory Group Maintains Market Perform on J.Jill, Maintains $31 Price Target

Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) founder Jeff Bezos and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk, two of the world&#8217;s wealthiest individuals, continue to chart distinctly different paths in their approaches to <a href="https://www.benzinga.com/news/24/12/42335531/jeff-bezos-counters-elon-musk-led-doge-cost-cutting-plan-says-america-needs-growth-orientation-heres-what-the-amazon-founder-said-to-tackle-national-debt">America&#8217;s economic challenges and business leadership</a>.
What Happened: At the recent New York Times DealBook Summit, Bezos advocated for addressing the national debt crisis through economic expansion rather than austerity measures. 
Amazon founder&#8217;s proposal centers on achieving 3-5% annual GDP growth while managing debt growth, contrasting with Musk&#8217;s emphasis on federal spending reduction through the upcoming Department of Government Efficiency under President-elect Donald Trump&#8216;s administration.
Their economic philosophies mirror their different paths to success. Since Amazon&#8217;s 1994 founding in a Bellevue garage, Bezos has built what became known as &#8220;the everything store,&#8221; transforming from an online bookstore into a global retail and technology powerhouse. 
Amazon&#8217;s stock has delivered staggering returns of 244,955% since its 1997 IPO at $18 per share, with current market capitalization reaching $2.319 trillion.
Musk, who joined Tesla in 2004 and became CEO in 2008, has led the electric vehicle manufacturer to significant growth, though at a different scale. 
Since Tesla&#8217;s 2010 IPO at $17 per share, the EV maker has generated returns of 28,766%, achieving a market capitalization of $1.186 trillion. The <a href="https://www.benzinga.com/quote/TSLA/earnings">company&#8217;s annual revenue</a> of $97.2 billion, while substantial, trails <a href="https://www.benzinga.com/quote/AMZN/earnings">Amazon&#8217;s $620.1 billion</a>.
See Also: <a href="https://www.benzinga.com/markets/equities/24/12/42356725/alex-karp-supports-doge-as-trump-taps-palantirs-shyam-shankar-for-border-security-role-cannot-have-a-better-person-than-musk">Alex Karp Supports DOGE, As Trump Taps Palantir&#8217;s Shyam Shankar For Border Security Role: &#8216;Cannot Have A Better Person Than Musk&#8217;</a>
Their rivalry extends beyond business metrics. Recent tensions surfaced when <a href="https://www.benzinga.com/general/entertainment/24/11/42120619/jeff-bezos-denies-elon-musks-allegation-that-he-told-people-to-sell-tesla-stock-100-not-true">Musk accused Bezos</a> of privately urging investors to divest from Tesla and SpaceX stocks, allegations Bezos denied. 
The competition has also <a href="https://www.benzinga.com/general/space/24/09/40697380/bezos-vs-musk-battle-heads-to-space-how-amazon-founder-is-taking-tesla-ceo-on-more-directly">spread to space exploration</a>, where Musk&#8217;s SpaceX pursues Mars colonization while Bezos&#8217;s Blue Origin focuses on suborbital flight and space habitation projects.
The billionaires&#8217; wealth reflects their companies&#8217; success, with Musk leading the Bloomberg Billionaire Index at $362 billion, followed by Bezos at $240 billion. Despite their different approaches, both have transformed their respective industries while maintaining significant influence in American business and technology sectors.
Current market <a href="https://www.benzinga.com/pro/">data from Benzinga Pro</a>, shows Amazon trading at $220.55 with a price-earnings ratio of 47.27, while Tesla trades at $369 with a P/E ratio of 101.31. Amazon&#8217;s year-to-date gains stand at 47.10%, comparable to Tesla&#8217;s 48.74%.
Musk has secured a position in the incoming Trump administration. Bezos, on the other hand, has expressed optimism about potential <a href="https://www.benzinga.com/media/24/12/42331420/jeff-bezos-optimistic-about-trumps-second-term-wants-to-help-streamline-rules-we-do-have-too-many-regulations-in-this-country">regulatory reductions under Trump&#8217;s leadership</a>. He has also emphasized his return to Amazon&#8217;s regular operations, particularly in enabling AI, after stepping down as CEO in 2021.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/media/24/12/42356920/amazon-halts-inferentia-ai-chip-development-to-take-on-nvidia-how-trainium-is-shaping-up-to-be-the-new-weapon-in-ai-chip-wars">Amazon Halts Inferentia AI Chip Development To Take On Nvidia: How Trainium Is Shaping Up To Be The New Weapon In AI Chip Wars</a></li>
</ul>
Image made via photos on Shutterstock
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Economics

Markets

AMZN

TSLA

As Jeff Bezos And Elon Musk Clash Over Economic Solutions, Amazon And Tesla's Shareholder Returns Highlight Stark Contrasts — Here's How Both Companies Stack Up

Needham analyst Tom Nikic reiterates Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) from Hold to Hold.

Needham Reiterates Hold on Lululemon Athleticato Hold

Telsey Advisory Group analyst Dana Telsey maintains Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) with a Outperform and raises the price target from $450 to $500.

ULTA

Telsey Advisory Group Maintains Outperform on Ulta Beauty, Raises Price Target to $500

Shares of DocuSign, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) rose sharply in today's pre-market trading r after the company reported better-than-expected third-quarter financial results and issued FY25 revenue <a href="https://www.benzinga.com/news/earnings/24/12/42352653/docusign-stock-soars-on-q3-earnings-beat-revenue-beat-strong-guidance">guidance above estimates</a>.
DocuSign reported third-quarter revenue of $754.8 million, beating the consensus estimate of $745.26 million. The company reported third-quarter adjusted earnings of 90 cents per share, beating analyst estimates of 87 cents per share, according to Benzinga Pro.
DocuSign shares jumped 14.1% to $95.43 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Universe Pharmaceuticals INC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) gained 196.2% to $3.11 in pre-market trading after dipping 41% on Thursday.</li>
<li>Zhibao Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBAO#NASDAQ">ZBAO</a>) rose 111.7% to $5.08 in pre-market trading after the company announced they will partner with PICC &amp; Munich Re to develop new medical insurance products in China.</li>
<li>Color Star Technology Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADD#NASDAQ">ADD</a>) gained 82.2% to $6.94 in pre-market trading after the company announced that it regained Nasdaq compliance.</li>
<li>Gaxos.ai Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GXAI#NASDAQ">GXAI</a>) gained 48.6% to $2.11 in pre-market trading after gaining over 10% on Thursday.</li>
<li>The Lion Electric Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEV#NYSE">LEV</a>) gained 43.3% to $0.48 in pre-market trading. Lion Electric reached a definitive agreement in respect of the sale of Innovation Center located in Mirabel, Québec for a purchase price of C$50 million.</li>
<li>Primega Group Holdings Limited  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGHL#NASDAQ">PGHL</a>) rose 40.1% to $1.87 in pre-market trading after dipping over 15% on Thursday.</li>
<li>Rubrik, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) gained 23.2% to $66.11 in pre-market trading as the company reported better-than-expected results for its third quarter.</li>
<li>Asana, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) climbed 21.3% to $18.75 in pre-market trading after the company reported better-than-expected third-quarter financial results and issued FY25 guidance above estimates.</li>
<li>Satellogic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATL#NASDAQ">SATL</a>) gained 12.1% to $3.52 in pre-market trading after jumping 20% on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Oriental Rise Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORIS#NASDAQ">ORIS</a>) shares tumbled 81.23 to $10.50 in pre-market trading after surging 599% on Thursday.</li>
<li>zSpace, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZSPC#NASDAQ">ZSPC</a>) declined 31.7% to $15.01 in pre-market trading after jumping 340% on Thursday.</li>
<li>Foxx Development Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXX#NASDAQ">FOXX</a>) shares fell 24.7% to $3.73 in pre-market trading after jumping 55% on Thursday.</li>
<li>PainReform Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRFX#NASDAQ">PRFX</a>) shares fell 23.4% to $3.44 in pre-market trading. PainPerform shares jumped 68% on Thursday after the company announced changes in management including new CFO and CEO appointees.</li>
<li>Virpax Pharmaceuticals, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) fell 21.5% to $0.3069 in pre-market trading after declining around 5% on Thursday.</li>
<li>CAMP4 THERAPEUTICS CORPORATION (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) fell 21.4% to $7.71 in pre-market trading after gaining 66% on Thursday.</li>
<li>Protara Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARA#NASDAQ">TARA</a>) fell 17.9% to $4.94 in pre-market trading. Protare Therapeutics shares jumped 70% on Thursday after the company announced results from its ongoing Phase 2 TARA-002 trial in patients with NMIBC.</li>
<li>Molecular Templates, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEM#NASDAQ">MTEM</a>) dipped 17.1% to $0.4472 in pre-market trading after jumping 60% on Thursday.</li>
<li>Mawson Infrastructure Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIGI#NASDAQ">MIGI</a>) shares dipped 16.7% to $1.10 in pre-market trading after jumping 94% on Thursday.</li>
<li>Smith &amp; Wesson Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) fell 15.8% to $11.48 in today's pre-market trading after the company reported second-quarter results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42357598/dow-dips-more-than-200-points-ahead-of-jobs-report-investor-sentiment-declines-fear-greed-index-remains-in-greed-zone">Dow Takes A Breather After Record Close, Dips Over 200 Points Ahead Of Jobs Report: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

Movers

Trading Ideas

ASAN

CAMP

DOCU

FOXX

GXAI

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

MTEM

ORIS

PGHL

PRFX

RBRK

SATL

SWBI

TARA

VRPX

ZBAO

ZSPC

Why DocuSign Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Telsey Advisory Group analyst Dana Telsey maintains PVH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) with a Outperform and maintains $130 price target.

Comments

Bellevue Life Sciences

News

Latest news for Bellevue Life Sciences (NASDAQ:BLACW) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga